<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="correction"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40013135</article-id><article-id pub-id-type="pmc">PMC11862822</article-id><article-id pub-id-type="doi">10.3389/fimmu.2025.1561850</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Correction</subject></subj-group></subj-group></article-categories><title-group><article-title>Corrigendum: Distinction of early complement classical and lectin pathway activation <italic>via</italic> quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hurler</surname><given-names>Lisa</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1220559"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Toonen</surname><given-names>Erik J. M.</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/869872"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Kajd&#x000e1;csi</surname><given-names>Erika</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>van Bree</surname><given-names>Bregje</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Brandwijk</surname><given-names>Ricardo J. M. G. E.</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1706284"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>de Bruin</surname><given-names>Wieke</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1981072"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Lyons</surname><given-names>Paul A.</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/551565"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Bergamaschi</surname><given-names>Laura</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1998397"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><collab>Cambridge Institute of Therapeutic Immunology Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration</collab></contrib><contrib contrib-type="author"><name><surname>Sinkovits</surname><given-names>Gy&#x000f6;rgy</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/549395"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Cervenak</surname><given-names>L&#x000e1;szl&#x000f3;</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>W&#x000fc;rzner</surname><given-names>Reinhard</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/30430"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Proh&#x000e1;szka</surname><given-names>Zolt&#x000e1;n</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><xref rid="fn001" ref-type="author-notes">
<sup>*</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/236721"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>Department of Internal Medicine and Haematology, Semmelweis University</institution>, <addr-line>Budapest</addr-line>, <country>Hungary</country>
</aff><aff id="aff2">
<sup>2</sup>
<institution>Research and Development Department</institution>, <addr-line>Hycult Biotech, Uden</addr-line>, <country>Netherlands</country>
</aff><aff id="aff3">
<sup>3</sup>
<institution>Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge</institution>, <addr-line>Cambridge</addr-line>, <country>United Kingdom</country>
</aff><aff id="aff4">
<sup>4</sup>
<institution>Department of Medicine, University of Cambridge, Addenbrooke&#x02019;s Hospital</institution>, <addr-line>Cambridge</addr-line>, <country>United Kingdom</country>
</aff><aff id="aff5">
<sup>5</sup>
<institution>Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck</institution>, <addr-line>Innsbruck</addr-line>, <country>Austria</country>
</aff><aff id="aff6">
<sup>6</sup>
<institution>Research Group for Immunology and Haematology, Semmelweis University &#x02013; E&#x000f6;tv&#x000f6;s Lor&#x000e1;nd Research Network (Office for Supported Research Groups)</institution>, <addr-line>Budapest</addr-line>, <country>Hungary</country>
</aff><author-notes><fn fn-type="edited-by"><p>Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland</p></fn><corresp id="fn001">*Correspondence: Zolt&#x000e1;n Proh&#x000e1;szka, <email xlink:href="mailto:prohaszka.zoltan@med.semmelweis-univ.hu">prohaszka.zoltan@med.semmelweis-univ.hu</email>
</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>12</day><month>2</month><year>2025</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>16</volume><elocation-id>1561850</elocation-id><history><date date-type="received"><day>16</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>28</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Hurler, Toonen, Kajd&#x000e1;csi, van Bree, Brandwijk, de Bruin, Lyons, Bergamaschi, Cambridge Institute of Therapeutic Immunology Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration, Sinkovits, Cervenak, W&#x000fc;rzner and Proh&#x000e1;szka</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Hurler, Toonen, Kajd&#x000e1;csi, van Bree, Brandwijk, de Bruin, Lyons, Bergamaschi, Cambridge Institute of Therapeutic Immunology Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration, Sinkovits, Cervenak, W&#x000fc;rzner and Proh&#x000e1;szka</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><related-article related-article-type="corrected-article" ext-link-type="doi" id="RA1" xlink:href="10.3389/fimmu.2022.1039765" journal-id="Front Immunol" journal-id-type="nlm-ta">A Corrigendum on <article-title>Distinction of early complement classical and lectin pathway activation <italic>via</italic> quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs</article-title> By Hurler L, Toonen EJM, Kajd&#x000e1;csi E, van Bree B, Brandwijk RJMGE, de Bruin W, Lyons PA, Bergamaschi L, Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration, Sinkovits G, Cervenak L, W&#x000fc;rzner R and Proh&#x000e1;szka Z (2022) <italic>Front. Immunol.</italic> 13:1039765. doi:&#x000a0;<object-id>10.3389/fimmu.2022.1039765</object-id>
</related-article><kwd-group><kwd>early complement activation</kwd><kwd>classical pathway activation</kwd><kwd>lectin pathway activation</kwd><kwd>C1-INH complexes</kwd><kwd>assay development and validation</kwd><kwd>C1s/C1-INH complex</kwd><kwd>MASP-1/C1-INH complex</kwd></kwd-group><counts><fig-count count="0"/><table-count count="0"/><equation-count count="0"/><ref-count count="0"/><page-count count="2"/><word-count count="173"/></counts><custom-meta-group><custom-meta><meta-name>section-in-acceptance</meta-name><meta-value>Molecular Innate Immunity</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>In the published article, there was an error in the <bold>Funding</bold> statement. One of the funding sources was missing from the original published statement. The correct Funding statement appears below. &#x0201c;The research was financed by the Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary, within the framework of the molecular biology thematic program of the Semmelweis University, &#x0201c;MOLORKIV&#x0201d;(TKP2021-EGA-24) to ZP. ZP, RW and LH are supported by funds of the EU MSCA project CORVOS 860044. The research was further funded by the Austrian Science Fund (FWF), HOROS W-1253. In addition, the research project (project number: 2020-1.1.6-J&#x000d6;V&#x00150;-2021-00013 to ZP) was further funded by the Ministry of Culture and Innovation with support from the National Research Development and Innovation Fund under the Investment into Future call (2020-1.1.6-J&#x000d6;V&#x00150;) programme.&#x0201d;</p><p>The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.</p></body><back><sec sec-type="disclaimer" id="s1"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec></back></article>